Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.155
+0.025 (0.80%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Voyager Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 71.37 | 68.8 | 98.96 | 117.43 | 104.44 | Upgrade
|
| Short-Term Investments | 195.32 | 162.07 | 19.89 | 15.11 | 76.7 | Upgrade
|
| Cash & Short-Term Investments | 266.68 | 230.88 | 118.85 | 132.54 | 181.14 | Upgrade
|
| Cash Growth | 15.51% | 94.26% | -10.33% | -26.83% | -35.66% | Upgrade
|
| Accounts Receivable | 2.18 | 83.49 | 0.26 | 0.73 | 8.01 | Upgrade
|
| Other Receivables | 2.31 | 0.96 | 0.38 | 0.02 | 0.1 | Upgrade
|
| Receivables | 4.49 | 84.46 | 0.64 | 0.75 | 8.11 | Upgrade
|
| Prepaid Expenses | 0.43 | 0.61 | 0.7 | 1.36 | 1.46 | Upgrade
|
| Other Current Assets | 5.21 | 3.75 | 4.32 | 2.05 | 7.07 | Upgrade
|
| Total Current Assets | 276.81 | 319.68 | 124.5 | 136.7 | 197.77 | Upgrade
|
| Property, Plant & Equipment | 47.66 | 30 | 33.34 | 55.38 | 61.5 | Upgrade
|
| Long-Term Investments | 65.7 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | 2.87 | 1.59 | 1.52 | 1.78 | 2.32 | Upgrade
|
| Total Assets | 393.05 | 351.28 | 159.36 | 193.86 | 261.58 | Upgrade
|
| Accounts Payable | 4 | 1.6 | 2.57 | 0.57 | 0.63 | Upgrade
|
| Accrued Expenses | 14.17 | 16.82 | 7.82 | 10.95 | 14.21 | Upgrade
|
| Current Portion of Leases | 7.23 | 3.2 | 2.83 | 5.57 | 4.2 | Upgrade
|
| Current Unearned Revenue | 24.39 | 42.88 | 59.38 | 33.89 | 7.73 | Upgrade
|
| Total Current Liabilities | 49.79 | 64.51 | 72.59 | 50.98 | 26.77 | Upgrade
|
| Long-Term Leases | 36.5 | 17.09 | 20.29 | 38.61 | 43.41 | Upgrade
|
| Long-Term Unearned Revenue | 6 | 32.36 | 6.45 | 8.21 | 36.09 | Upgrade
|
| Other Long-Term Liabilities | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Total Liabilities | 93.29 | 114.96 | 100.34 | 98.8 | 107.26 | Upgrade
|
| Common Stock | 0.06 | 0.04 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Additional Paid-In Capital | 626.3 | 497.51 | 452.71 | 442.26 | 430.32 | Upgrade
|
| Retained Earnings | -326.18 | -261.18 | -393.51 | -347.1 | -275.91 | Upgrade
|
| Comprehensive Income & Other | -0.41 | -0.05 | -0.22 | -0.14 | -0.13 | Upgrade
|
| Total Common Equity | 299.76 | 236.32 | 59.02 | 95.06 | 154.32 | Upgrade
|
| Shareholders' Equity | 299.76 | 236.32 | 59.02 | 95.06 | 154.32 | Upgrade
|
| Total Liabilities & Equity | 393.05 | 351.28 | 159.36 | 193.86 | 261.58 | Upgrade
|
| Total Debt | 43.73 | 20.29 | 23.13 | 44.18 | 47.61 | Upgrade
|
| Net Cash (Debt) | 288.66 | 210.58 | 95.72 | 88.36 | 133.53 | Upgrade
|
| Net Cash Growth | 37.08% | 119.99% | 8.33% | -33.83% | -46.43% | Upgrade
|
| Net Cash Per Share | 5.01 | 4.72 | 2.50 | 2.35 | 3.58 | Upgrade
|
| Filing Date Shares Outstanding | 55.21 | 54.3 | 43.29 | 38.11 | 37.65 | Upgrade
|
| Total Common Shares Outstanding | 54.73 | 44.04 | 38.61 | 37.92 | 37.37 | Upgrade
|
| Working Capital | 227.02 | 255.18 | 51.91 | 85.72 | 171 | Upgrade
|
| Book Value Per Share | 5.48 | 5.37 | 1.53 | 2.51 | 4.13 | Upgrade
|
| Tangible Book Value | 299.76 | 236.32 | 59.02 | 95.06 | 154.32 | Upgrade
|
| Tangible Book Value Per Share | 5.48 | 5.37 | 1.53 | 2.51 | 4.13 | Upgrade
|
| Machinery | 22.67 | 23.16 | 22.01 | 21.91 | 20.5 | Upgrade
|
| Construction In Progress | - | - | - | - | 0.87 | Upgrade
|
| Leasehold Improvements | 6.49 | 7.11 | 12.55 | 15.7 | 15.47 | Upgrade
|
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.